Jack Elands
Directeur Général chez Emergence Therapeutics AG
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Xavier Preville | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Peter Neubeck | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | 5 ans |
Thierry Laugel | M | 57 |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | - |
Aristotelis Nastos | M | 56 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Irina Staatz-Granzer | M | 64 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | 5 ans |
Franck Grimaud | M | 58 |
BliNK Biomedical SAS
BliNK Biomedical SAS BiotechnologyHealth Technology BliNK Biomedical SAS is a French company that specializes in cutting-edge technology for identifying rare antibody-secreting cells from humans and other species. The company is based in Marseille, France. The company's technology is based on validated platforms, isaac and vivascreen, which provide a highly efficient and deep mining process. The CEO of the company is Jack Elands. | - |
Ohad Hammer | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Matthew Hammond | M | 35 |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Roy Amariglio | M | - |
Emergence Therapeutics AG
Emergence Therapeutics AG Pharmaceuticals: MajorHealth Technology Emergence Therapeutics AG is biopharmaceutical company. It develops novel antibody drug conjugate. The company was founded by Jack Elands and Xavier Preville and is headquartered in Duisburg, Germany. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Patrick de van der Schueren | M | - |
University of Utrecht
| 7 ans |
Sjef de Kimpe | M | - |
University of Utrecht
| 10 ans |
J. F. M. Westendorp | M | 68 |
University of Utrecht
| 5 ans |
Maarten Leo Pronk | M | 69 |
University of Utrecht
| 1 ans |
Lilian Haagsman | F | - |
University of Utrecht
| 3 ans |
Joost Dröge | M | - |
University of Utrecht
| 5 ans |
Thijs Berman | M | 66 |
University of Utrecht
| 4 ans |
Joost Lagendijk | M | 67 |
University of Utrecht
| 4 ans |
Berend Scheffers | M | - |
University of Utrecht
| 4 ans |
Gerald Winkels | M | 68 |
University of Utrecht
| 1 ans |
Adrianus Johannes Antonius Kas | M | - |
University of Utrecht
| 1 ans |
Philip A. van Damme | M | 70 |
University of Utrecht
| 3 ans |
Huub den Rooijen | M | - |
University of Utrecht
| 4 ans |
Leon Hooftman | M | - |
University of Utrecht
| 3 ans |
Maarten Antonius Johannes van den Belt | M | - |
University of Utrecht
| 4 ans |
Ronald E. E. Scherpenhuijsen Rom | M | 65 |
University of Utrecht
| 4 ans |
Gerardus Wilhelmus van Odijk | M | 67 |
University of Utrecht
| 3 ans |
Heiko Balder | M | - |
University of Utrecht
| 1 ans |
Bharat Tewarie | M | - |
University of Utrecht
| 4 ans |
Jeff Gielen | M | 72 |
University of Utrecht
| 3 ans |
Peter van Stiphout | M | - |
University of Utrecht
| 3 ans |
Adrianus van Wijk | M | 68 |
University of Utrecht
| 4 ans |
Kees van der Leun | M | - |
University of Utrecht
| 4 ans |
Marco Baptist Arie Keim | M | 62 |
University of Utrecht
| 3 ans |
Aalt Dijkhuizen | M | 70 |
University of Utrecht
| 3 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Pays-Bas | 25 | 73,53% |
Allemagne | 7 | 20,59% |
France | 2 | 5,88% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Jack Elands
- Réseau Personnel